ANI Pharmaceuticals, Inc.
Ticker(s):
ANIP
Country:
Sector & Industry:
Business Overview
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Contact & Other Information
Number of Employees:
897
Website:
,
,
ANI Pharmaceuticals announces FDA approval for expanded label of ILUVIEN® for treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.